Although many people with plaque psoriasis can control their symptoms by using topical treatments that are applied to the skin, some people with moderate or severe plaque psoriasis do not get enough ...
Three years after AbbVie stood at the edge of a major patent cliff with the loss of exclusivity for immunology ...
AbbVie (ABBV) fell ~4% on Wednesday as BNP Paribas argued that its immunology blockbuster Skyrizi could face competition from Icotyde, a newly approved plaque psoriasis pill developed by Johnson & ...
People with psoriatic arthritis (PsA) often take medicines to help manage their condition and improve their symptoms. Some of these medicines work directly on the body’s immune system and help to ...
Immunocore’s Kimmtrak (tebentafusp-tebn; injection) has been approved for treating unresectable or metastatic uveal melanoma (mUM) in adults who are HLA-A*02:01 positive and have not received previous ...
Skyrizi (risankizumab-rzaa) is a prescription drug used to treat certain autoimmune conditions, including plaque psoriasis and Crohn’s disease. It works by attaching to specific proteins in your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results